These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 991154)

  • 1. Serpentine supravenous 5-fluorouracil (NSC-19893) hyperpigmentation.
    Hrushesky WJ
    Cancer Treat Rep; 1976 May; 60(5):639. PubMed ID: 991154
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Serpentine supravenous fluorouracil hyperpigmentation.
    Hrushesky WJ
    JAMA; 1976 Jul; 236(2):138. PubMed ID: 947001
    [No Abstract]   [Full Text] [Related]  

  • 3. Unusual pigmentary changes associated with 5-fluorouracil therapy.
    Hrushesky WJ
    Cutis; 1980 Aug; 26(2):181-82. PubMed ID: 7408538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antineoplastic agent-associated serpentine supravenous hyperpigmentation: superficial venous system hyperpigmentation following intravenous chemotherapy.
    Geddes ER; Cohen PR
    South Med J; 2010 Mar; 103(3):231-5. PubMed ID: 20134385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpentine supravenous pigmentation. A rare vasculo-cutaneous effect induced by systemic 5-fluorouracil.
    Rao R; Balachandran C
    Indian J Dermatol Venereol Leprol; 2010; 76(6):714-5. PubMed ID: 21079327
    [No Abstract]   [Full Text] [Related]  

  • 6. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
    Chan CC; Lin SJ
    N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
    [No Abstract]   [Full Text] [Related]  

  • 7. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 8. Serpentine supravenous streaks induced by 5-fluorouracil.
    Jain V; Bhandary S; Prasad GN; Shenoi SD
    J Am Acad Dermatol; 2005 Sep; 53(3):529-30. PubMed ID: 16112371
    [No Abstract]   [Full Text] [Related]  

  • 9. Unusual serpentine hyperpigmentation associated with 5-fluorouracil. Case report and review of cutaneous manifestations associated with systemic 5-fluorouracil.
    Vukelja SJ; Bonner MW; McCollough M; Cobb PW; Gaule DA; Fanucchi PJ; Keeling JH
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 2):905-8. PubMed ID: 1837033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 11. Canities--reversal with chemotherapy.
    Babu KG; Rasheshyam D; Lalitha N
    J Assoc Physicians India; 1995 Aug; 43(8):577. PubMed ID: 8772986
    [No Abstract]   [Full Text] [Related]  

  • 12. Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine.
    Claudy AL; Lévigne V; Boucheron S
    Dermatology; 1992; 184(1):70-2. PubMed ID: 1559000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigmented purpuric dermatosis-like reaction to topical fluorouracil.
    Voelter WW
    Arch Dermatol; 1983 Nov; 119(11):875-6. PubMed ID: 6685460
    [No Abstract]   [Full Text] [Related]  

  • 14. Persistent supravenous erythematous eruption: a rare local complication of intravenous 5-fluorouracil therapy.
    Pujol RM; Rocamora V; Lopez-Pousa A; Taberner R; Alomar A
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 2):839-42. PubMed ID: 9810911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Iatrogenic dyschromia of the face].
    Collard JJ
    Arch Belg Dermatol; 1974; 30(4):301-2. PubMed ID: 4283360
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistent serpentine supravenous hyperpigmentation--a possible cutaneous manifestation of HIV infection or a normal racial variant: a report of 3 cases.
    O'Malley JT; Lieb JL; Weiser JA; Grossman ME
    Skinmed; 2013; 11(2):93-4. PubMed ID: 23745227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration in nail pigment after chemotherapy.
    Daoud D; Fox N; Tan J
    Arch Intern Med; 1977 Sep; 137(9):1259. PubMed ID: 901099
    [No Abstract]   [Full Text] [Related]  

  • 18. Serpentine Supra-venous Hyperpigmentation "Badge of Courage" in Fight Against Cancer: An Brief Review.
    Narayan S; Talwar V; Redhu P; Goel V; Jain A; Soni S; Chaudhary K; Basu D
    Gulf J Oncolog; 2022 Sep; 1(40):83-87. PubMed ID: 36448076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil-induced bilateral persistent serpentine supravenous hyperpigmented eruption, bilateral mottling of palms and diffuse hyperpigmentation of soles.
    Suvirya S; Agrawal A; Parihar A
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25336557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.